Precision Medicine for Treating Alzheimer’s Disease in Down Syndrome
Sonal Sukreet, Elise K Kim, Melissa Petersen, Fan Zhang, Mary Sano, Paul S S Aisen, Howard F Andrews, Sid E O'Bryant, Michael Rafii, Robert A Rissman · 2025
Read Precision Medicine for Treating Alzheimer’s Disease in Down Syndrome by Sonal Sukreet, Elise K Kim, Melissa Petersen, Fan Zhang, Mary Sano, Paul S S Aisen, Howard F Andrews, Sid E O'Bryant, Michael Rafii, Robert A Rissman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716916.txt.
Description
Sonal Sukreet and co-authors revisit a finished vitamin E trial to find which patients it actually helped, in this 2025 study. The patients had Down syndrome, a group that develops a genetic form of Alzheimer's disease. Vitamin E showed no overall benefit in the trial, so the team tested whether an inflammation profile could pick out responders.
Blood samples banked at the trial's start and end were assayed for inflammation and brain injury markers. A learning model combined ten inflammation markers with genetic and personal factors. The profile predicted who responded to treatment with very high accuracy. Brain markers added further signal. The work argues for matching anti-inflammatory therapy to the patient.
Catalog record
| CREATOR | Sonal Sukreet, Elise K Kim, Melissa Petersen, Fan Zhang, Mary Sano, Paul S S Aisen, Howard F Andrews, Sid E O'Bryant, Michael Rafii, Robert A Rissman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |